Podcasts about zepbound

In this episode of the Irresistible You podcast, we're diving into what it means to embrace your cozy or “soft life” era, without the guilt. I used to think that doing cozy things like diamond painting or relaxing at home was lazy… or worse, that stillness would lead to weight gain. I thought if it didn't make money or burn calories, it was a waste of time. But now I know better.I'm sharing how I've started doing things that pull me rather than constantly pushing myself and how that shift has helped me stop emotional eating, feel more grounded, and finally listen to my body. Cozy isn't laziness, it's restoration.If you've ever felt stuck between hustle culture and burnout, this episode is for you.

What up, Beasts. Welcome back to the show! This week on the Unveiling the Beast podcast, I sat down with Katie Sorensen, a nurse practitioner and owner of Weight Loss NP, to dig into one of the most misunderstood topics on the internet right now: GLP-1 medications. You know, the ones people love to hate, like Ozempic and ZepBound. As someone who's been waist-deep in the research for months (because yes, that's what us nerdy, weight-neutral coaches do), I wanted to bring nuance and facts into a conversation that's gotten way too loud and way too shallow. Katie broke down what these meds actually are, how they work with your body (not against it), and why calling them “the easy way out” is just lazy and harmful. Spoiler: they've been around for decades, are made of naturally occurring peptides, and they're doing a hell of a lot more than shrinking waistlines.We also talked about the emotional weight behind physical weight, the ridiculous judgment people face for using science to support their health, and how these meds are turning down the obsessive food noise that steals so much brain space. Katie and I are both on the same page: it's not about glorifying weight loss. It's about freeing people to focus on what actually matters in life. We covered everything from muscle preservation to mental health to why strength training is the real anti-aging hack. And if you've ever looked at someone using a weekly injection and thought, “Must be nice,” this episode will shift your perspective. As always, we ended with some wisdom, and Katie's was simple and powerful: get outside, soak in the sunshine, and walk. Because sometimes, the best medicine is free and found in the fresh air.As always, I hope something lands with you today. I hope something you hear tugs at your heart strings and/or I hope you laugh.Bio: Katie Sorensen, NP-C, is a passionate Nurse Practitioner dedicated to transforming lives through her innovative and holistically focused practice, Weight Loss NP, LLC. With a mission to empower individuals to achieve optimal health and vitality, Weight Loss NP specializes in personalized medical weight loss and metabolic health solutions that deliver real and lasting results.Music by Prymary: Sean Entrikin (my hot husband) on guitar, Chris Quirarte on drums, Smiley Sean on keyboards, Rob Young on bass, and Jaxon Duane on vocals.Previous Episodes about GLP-1s151 This Might Be The Most Honest GLP-1 Conversation on the Internet154 The Science of GLP-1s and Why it's Blowing My MindGLP-1 Studies I've looked at: https://storage.googleapis.com/msgsndr/AX1su0J5xvxdddMmNWzF/media/685765ea077fba411ec88ff3.pdfConnect with Katie!Website: www.theWLNP.comYouTube: www.youtube.com/@WeightLossNPFacebook: https://www.facebook.com/weightlossnpcoWhere can you find me?Linktree: https://linktr.ee/beautifulbeastwithinstudiosWhat if health wasn't about rules or restriction?What if it felt more like trust, ease, and actually liking the person in the mirror?I help people rebuild their relationship with food, movement, and themselves, so health becomes something you live, not something you chase.Ready for a different kind of conversation? Let's talk. No pressure.https://beautifulbeastwithinstudios.com/exploration-chat-schedulingAffiliate LinksBreakthrough Coaching Certification: If you feel called to help others heal or grow, Sean Smith's Breakthrough Coaching Certification is where that calling becomes real. https://coachseansmith.ontraport.net/t?orid=27037&opid=43Opus Clip: I use Opus Clip mostly for captions, and it's a game-changer for turning long videos into usable clips. If you use my link, it supports the show, and I appreciate you big time! https://www.opus.pro/?via=1118d2Mary Kay: Grab your faves here: https://www.marykay.com/kaitienoelleUnveil the Beautiful Beast Within YOU!Zoom Background:By Behr

In this episode, we dive deep into the biggest stories shaping the markets right now. Intel has officially fallen out of the top 10 semiconductor companies — is it too late for them to catch up, and which 3 chipmakers should investors focus on instead? We also break down how stock options can be used as a powerful wealth-building tool when used the right way.With Nvidia flirting with a $4 trillion valuation after an explosive 870% AI-led rally, we discuss whether it's headed for a meltdown or another breakout — and which overlooked metric might signal what's next. Bitcoin also hit a new all-time high heading into Crypto Week, and we break down what this means for the broader crypto market.Next, we analyze who the real winners and losers in Big Tech have been since Trump took office, and what it means for investors moving forward. With U.S. equity fund inflows collapsing from $31.6 billion to just $2.1 billion, we ask: are you buying the dip or parking cash on the sidelines? Lastly, we look at Eli Lilly and whether its new Zepbound pill could drive a potential 40% surge in the stock over the next year.EYLU 24 Hour 50% off Sale (Code: Marketmondays) https://eyluniversity.comInvest Fest Ticket Link: https://investfest.com#Investing #StockMarket #Crypto #Bitcoin #Nvidia #Intel #EliLilly #Zepbound #TechStocks #InvestFest #EarnYourLeisure #MarketMondays #FinancialFreedom #OptionsTradingOur Sponsors:* Check out PNC Bank: https://www.pnc.comSupport this podcast at — https://redcircle.com/marketmondays/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Driveway Beers PodcastWeight Loss and The Yukon!!We've been saying that we'd update you on our weight loss for 3 episodes now and we failed to come through. But this week, we fullfill the promise and give an update on Mike and Alex's weight loss (or gains) since the last episode. And the saga of the 04 Yukon Denali continues. Did Alex finally get it sorted out?? Why won't he just buy a new car already?? #cars #suv #weight #loss #weightloss #health #ozempic #zepbound #drugs #conservative #liberal #GeneralMotors #autos Please subscribe and rate this podcast on your podcast platforms like Apple and Spotify as it helps us a ton. Also like, comment, subscribe and share the video on Youtube. It really helps us get the show out to more people. We hope you enjoyed your time with us and we look forward to seeing you next time. Please visit us at https://drivewaybeerspodcast.com/donate/ to join The Driveway Club and buy us a bourbon! Buy us a bottle and we'll review it on a show!Leave us a comment and join the conversation on our discord at https://discord.gg/rN25SbjUSZ.Please visit our sponsors:Adam Chubbuck of Team Alpha Charlie Real Estate, 8221 Ritchie Hwy, Pasadena, MD 21122, www.tacmd.com, (443) 457-9524. If you want a real estate agent that will treat your money like it's his own and provide you the best service as a buyer or seller, contact Adam at Team Alpha Charlie.If you want to sponsor the show, contact us at contact@drivewaybeerspodcast.comCheck out all our links here https://linktr.ee/drivewaybeerspodcast.comIf you're looking for sports betting picks, go to conncretelocks.com or send a message to Jeremy Conn at Jconn22@gmail.comFacebook Page https://www.facebook.com/drivewaybeerspodcast/#podcast #whiskey #bourbon

Did you know that stopping GLP-1 medications like Ozempic or Wegovy can trigger powerful biological and emotional changes that impact your weight journey? In this episode, I talk about what happens when you stop taking a GLP-1 medication, like Ozempic, Wegovy, or Zepbound. I explain how these medications work by slowing stomach emptying, reducing appetite, and helping with insulin regulation, which supports weight loss and benefits conditions like type 2 diabetes and PCOS. However, I also share that they're not magic pills, you still need healthy habits like eating well and exercising. I highlight possible side effects, such as nausea or pancreatitis risks, and emphasize that stopping these medications can lead to increased hunger, cravings, weight regain, and even emotional distress. But I also reassure you that this isn't a sign of failure. Weight regain is often biological, not personal. I offer tips for tapering off safely, reinforcing lifestyle habits, and exploring other options. Most importantly, I remind you that your journey is valid, you're not alone, and lasting success requires a plan, support, and self-compassion. Tune in to learn what really happens when you stop taking GLP-1 medications—and how to stay empowered and in control of your weight journey.   Episode Highlights: How GLP-1 medications like Ozempic and Wegovy work Common side effects and safety considerations What to expect when stopping GLP-1s, both physically and emotionally Strategies to manage weight regain and maintain healthy habits Alternative tools and support options beyond medication Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

As GLP-1 drugs like Ozempic and Zepbound took the world by storm, Novo Nordisk and Eli Lilly faced a massive question: how do you fill the need at maximum speed? This week, we pull back the curtain on the strategies that allowed both companies to scale their manufacturing and cement market dominance, offering takeaways for any leader navigating unprecedented demand. Featuring: Principal Analysts Caroline Chumakov and Jenna Fink.Contextualizing the appetite for GLP-1s (0:46)Build, buy, acquire: How Novo Nordisk and Eli Lilly are meeting demand (04:05)The implications of Novo Nordisk's $16.5 billion Catalent acquisition (05:53)How to decide whether to acquire or outsource (07:23)Where in the world is GLP-1 manufacturing going next? (10:36)DTC, telehealth, and the future of GLP-1 channel strategy (13:16)How AI is driving pharma innovation at Novo Nordisk, Eli Lilly, Johnson & Johnson, and Merck (17:13)

Skinny Bones: An Overlooked Risk of Modern Weight Loss TreatmentIf you're considering or already using weight loss injections like Ozempic, Zepbound,  or Wegovy, this is a conversation you can't afford to miss.In under 8 minutes, this episode of Dr. Pepper...Really? will open your eyes to a little-known health concern hiding behind the weight loss hype—bone loss. Host Dr. Gary Pepper, a seasoned endocrinologist, introduces Linda, a postmenopausal woman weighing her options, to explore the deeper risks tied to rapid weight reduction.What you'll learn:Why losing weight quickly—especially after menopause—could accelerate bone thinningThe silent risk of fractures and the shocking reality of post-fracture outcomesWhy the FDA doesn't require bone safety data in weight loss drug trialsWhat simple screening and prevention steps you should be taking nowHow to protect yourself from malnutrition and bone loss with the right tools and knowledgeUnlike typical wellness advice, this podcast digs into the real science and unspoken gaps in our current weight loss culture. It's not about fear—it's about informed choices. You'll walk away with practical strategies and a new perspective on how to lose weight without losing your health.The podcast also introduces listeners to semagludiet.com, a one-stop resource designed to support people using GLP-1 medications. The site features free tools, meal plans, and the CSS Diet System—an innovative plate and bowl set that promotes portion control while maintaining nutrient density, helping you preserve muscle and bone during weight loss.This conversation also highlights the role of metabolism.com and the Dr. Pepper...Really? podcast in giving voice to medical concerns that often fly under the radar. When public messaging from pharmaceutical companies or regulators fails to capture the full picture, we step in to fill the gap with real talk backed by medical insight.And if you're wondering why you haven't heard this anywhere else, you're not alone. The lack of public awareness may not be accidental—but this podcast isn't about finger-pointing. It's about empowerment through information.Whether you're a healthcare consumer, a concerned friend, or just curious about what's really going on behind the headlines, this episode will change how you view weight loss treatments—and what questions you should be asking next.Disclaimer: This podcast is for informational purposes only and does not constitute medical advice. Please consult your personal healthcare provider for diagnosis and treatment decisions.Portions of this episode have been enhanced using artificial intelligence to optimGary Pepper, M.D., an associate professor at a prominent medical school and endocrinologist with 40 years of experience, brings clarity to numerous topics within the field of metabolic health. His view points are unhindered by corporate interests, unlike many other current "thought leaders" in medicine. Dr. Pepper, a dedicated educator, established his homebase website www.metabolism.com in 1996 and has blogged on important topics since then. Not one to be left behind by technology he began podcasting in 2020 with the onset of the pandemic and continues publishing vlogs on YouTube at his channel metabolism123. So whatever your choice in media, you will be gaining fresh insights by tuning in to his opinionated shows or reading his blogs on critical health topics.

VA cuts coming. The government's role is not to create jobs for people. CVS dropping Zepbound. What will Lilly's response be? Leftist loons compare ICE detention centers to concentration camps. Edgewood High School Sign for your car on the marketplace $800. Time to impeach Justice JacksonSee omnystudio.com/listener for privacy information.

Parents don't let your kids out late to shoot others. Trump sending weapons to Ukraine, after days before he said he wouldn't be sending weapons. Rift on the White House? Trump 8-1 SCOTUS win, guess who dissented? Public broadcasting cuts have arrived in Indiana. Honda unplugging SUV EV's. VA cuts coming. The government's role is not to create jobs for people. CVS dropping Zepbound. What will Lilly's response be? Leftist loons compare ICE detention centers to concentration camps. Edgewood High School Sign for your car on the marketplace $800. Time to impeach Justice Jackson. The Trolls are out. Tony tells Tara about them. Death toll in Texas is horrific. Home sellers are quitting the market. Now they are dangling the prosecutions of Comey and Brennan to try and make us forget about Epstein. Trump to tariff imported copper and pharmaceuticals? Caitlin Clark returns to the court today at Noon. Clark sells out seats, not Angel Reese.See omnystudio.com/listener for privacy information.

Ozempic continues to dominate conversations about weight loss, drawing attention from both the medical community and celebrity circles over the past week. This injectable medication, originally designed to manage type two diabetes, has increasingly become known for its ability to help people shed pounds. According to information from Northwestern University published just yesterday, users of Ozempic typically see a gradual but significant reduction in body weight, with clinical trials showing average losses of ten to fifteen percent over the course of a year. For most, the medication begins to make a noticeable difference after about six to eight weeks, particularly when combined with improved diet and regular exercise. However, experts are quick to caution that Ozempic is not a magic solution; sustainable weight loss still relies on lifestyle changes such as healthy eating and physical activity.In the last week, the public conversation around Ozempic has taken on new dimensions. One of the most visible aspects is its popularity among celebrities. According to coverage in the Financial Express from July seventh, high-profile users like Oprah Winfrey, Sharon Osbourne, Whoopi Goldberg, and Rebel Wilson have shared their experiences with Ozempic. Their stories have contributed to the drug's reputation as Hollywood's preferred method for rapid, dramatic weight reduction. However, this visibility has also drawn attention to some unexpected consequences. Dermatologists report an uptick in people experiencing what is now being called Ozempic mouth, a condition marked by significant volume loss and increased wrinkles around the mouth and jawline, which can result in an aged appearance. The rapid loss of facial fat has caused some to seek cosmetic treatments like dermal fillers or skin-tightening procedures to counteract these effects.Oprah Winfrey has been especially vocal and candid about her Ozempic journey in the past week. Reports from Deaconess Health and SheFinds note that Oprah has discussed the medication's role in her recent forty-pound weight loss, which she has attributed to Ozempic, healthy eating, and consistent exercise. During her recent trip to Venice for a celebrity wedding, Winfrey was photographed sporting a noticeably slimmer physique while working out with Gayle King. Fans on social media praised her transformation, and Winfrey herself has emphasized the importance of pairing any medication with dedication to overall well-being. Furthermore, Oprah recently hosted a "State of Weight" panel as part of her ongoing efforts to foster open discussion about weight loss, the struggles involved, and the tools that can help.While Ozempic maintains its position as a popular weight loss solution, new research published in The New England Journal of Medicine and reported by both HealthDay and AOL this week has challenged its supremacy. The study found that another medication, tirzepatide sold under the names Mounjaro and Zepbound, is even more effective at promoting weight loss. Participants taking tirzepatide averaged a twenty percent reduction in body weight, while those on Ozempic averaged about thirteen percent. Experts note that tirzepatide works on two hormone receptors instead of one, which seems to explain its stronger effect. Despite these new findings, Ozempic's influence remains powerful because of its proven track record and cultural prominence.Still, significant safety concerns persist regarding Ozempic's use for weight loss. The Motley Rice law firm and other health sources have reported ongoing lawsuits related to serious side effects, including gastrointestinal issues and, in rare cases, vision loss. Moreover, many patients regain much of the weight they lost if they discontinue the medication, pointing to the need for ongoing management and support rather than quick fixes.In summary, the past week has seen Ozempic's celebrity power and medical potential both celebrated and scrutinized. Oprah Winfrey's openness continues to resonate with many, highlighting that while medications like Ozempic can be helpful tools, the broader journey of weight management demands a holistic approach. The emergence of alternatives such as tirzepatide may shift the landscape, but one message remains clear from experts and high-profile users alike: sustainable weight loss requires lasting lifestyle change, not just a prescription.Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.ai

https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Have you ever wondered why some people seem to drop weight quickly on medications like Wegovy or Zepbound, while others barely budge?The truth is, weight loss isn't as simple as eating less or moving more and even powerful medications don't work the same for everyone. Results often depend on how these drugs are used, the lifestyle habits that support them, and individual factors like metabolism, other health conditions, and how well the body tolerates treatment.That's why it's important to rethink what “success” really means. For many, losing just 5% to 10% of body weight can make a huge difference, improving blood sugar, blood pressure, and cholesterol enough to lower the risk of serious health issues—even if the scale doesn't land exactly where they hoped.In this episode, we'll cover:What success really looks like on Wegovy or ZepboundWhy type 2 diabetes makes weight loss harder, even with GLP-1sHow alcohol use is one of the top reasons people don't see expected resultsThe role of habit snacking and how it can stall progressWhat to do when side effects get in the wayWhen these medications alone aren't enoughAnd what to explore if nothing seems to be workingHit play to find out the top reasons people fall short on Wegovy or Zepbound, how to spot them, and what might finally help you see progress.Connect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.co

Send us a message with this link, we would love to hear from you. Standard message rates may apply.On this episode discuss the side effects of GLP-1 medications like Ozempic and Wegovy, Zepbound, and Mounjaro offering practical strategies to manage these effects while still benefiting from the medications.• GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) help manage type 2 diabetes, obesity, and can reduce cardiovascular risk• Most common side effects are gastrointestinal: nausea, vomiting, diarrhea, bloating, and constipation• "Sulfur burps" are a frequently reported side effect that some manage with Pepto-Bismol• Start with low doses and increase slowly to minimize side effects• Eat smaller portions, avoid greasy/spicy foods, and practice mindful eating to reduce GI symptoms• Stay hydrated and increase fiber intake to prevent constipation• Gallbladder problems and pancreatitis risk may increase with rapid weight loss• Some evidence suggests potential vision changes requiring regular eye check-ups• Medications like insulin or blood pressure drugs may need adjustment when on GLP-1s• Most side effects improve with time as your body adjusts to the medicationSend us an email at yourcheckuppod@gmail.com or visit our Instagram or website to stay updated with weekly episodes released every Monday.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

CANETAS EMAGRECEDORAS E QUEDAS CAPILARESChegamos ao episódio sobre as famosas "canetas emagrecedoras" - Ozempic, Wegovy, Mounjaro e Zepbound - que revolucionaram o tratamento da obesidade e se tornaram o sonho de consumo de quem quer perder peso sem cirurgia. Mas será que essas medicações realmente são mais seguras para os cabelos, como sugerem os estudos oficiais?Hoje vamos revelar uma descoberta surpreendente: enquanto os ensaios clínicos reportam apenas 2,5% a 5,7% de queda capilar com essas medicações, a realidade clínica conta uma história bem diferente. Na prática médica diária, até 25% dos pacientes relatam algum grau de alteração capilar, especialmente aqueles que perdem mais de 20% do peso corporal. Vamos explorar essa discrepância entre os dados oficiais e o que realmente acontece nos consultórios.Você vai entender como funcionam os agonistas dos receptores GLP-1 e GIP, descobrir por que a semaglutida e a tirzepatida afetam os cabelos de maneiras ligeiramente diferentes, e principalmente, como a supressão extrema do apetite pode levar a deficiências nutricionais que sabotam o crescimento capilar. Mulheres têm mais que o dobro do risco comparado aos homens, e vamos explicar exatamente por quê.Mas a boa notícia é que essas medicações oferecem o melhor equilíbrio entre eficácia no emagrecimento e preservação capilar. Vamos compartilhar estratégias práticas como a técnica "proteína primeiro", protocolos de suplementação preventiva, e como ajustar doses quando necessário. Você também vai conhecer tratamentos capilares específicos para usuários dessas medicações e cronogramas realistas de recuperação.Se você está usando ou considerando usar essas medicações revolucionárias, este episódio vai te ensinar como aproveitar todos os benefícios mantendo seus cabelos saudáveis e sua autoestima em alta.#CanetasEmagrecedoras #Ozempic #Wegovy #Mounjaro #Zepbound #Semaglutida #Tirzepatida #GLP1 #QuedaCapilar #EmagrecimentoSeguro #SupressãoApetite #DeficiênciaProteica #TratamentoObesidade #MedicinaEmagrecimento #Tricologia #SaúdeCapilar #ProteinaFirst #SuplementaçãoPreventiva #TratamentoCapilar #DiabetesTipo2 #PerdaDePeso #MedicaçõesEmagrecedoras #AgonistasGLP1 #SaúdeDaMulher #MedicinaIntegrativa #TricologiaMédica #CuidadosCapilares #Prevenção #NutriçãoClínica #EndocrinologiaEmagrecimento

GLP-1's are tools and if you don't use them well, there's a cost. I'm a registered dietitian, speaker and author who works in the weight loss and GLP-1 space. Here are the 3 most important nutrition pitfalls to avoid if you want to feel your best on a GLP-1 like Ozempic, Mounjaro, Zepbound, & Wegovy.

Is there a better, safer, FREE alternative to Ozempic (and other GLP-1 drugs)? In this episode of Walk, Don't Run to the Doctor, Miles Hassell MD reacts to the growing buzz and shares a time-tested, evidence-based 3-step plan that outperforms popular weight loss drugs in the long run. As GLP-1 drugs like Ozempic, Wegovy, and Mounjaro surge in popularity, Dr. Hassell offers critical insight into their risks—like muscle loss, pancreatic complications, and long-term unknowns—while proposing a practical, natural alternative for lasting weight loss and better metabolic health. Key Takeaways: Why Big Pharma's track record with weight loss drugs demands caution The secret 3-step plan: Eat 6 servings of fruits & veggies, 3 minutes of daily exercise, reduce refined carbs Bonus tips: Bust cravings by eating protein with every meal, daily probiotics, and unlock the power of preemptive eating Why this plan costs nothing, has zero side effects, and starts showing results in just one week A timely message in light of the weight loss drug headlines—who should be in control of your health?  More references can be found at www.GreatMed.org Get your copy of Good Food Great Medicine. https://a.co/d/ajAzYzo Would you like Dr. Hassell to answer your question on the air? Contact us! Phone/text: 503-773-0770 e-mail: info@GreatMed.org Write us a letter. We love to hear from you. This podcast is sponsored by our generous listeners. Send questions, comments, and support to: 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 References: Chen, X., et al. (2025). Association of dietary fiber intake with all-cause and cardiovascular mortality in diabetes and prediabetes. Diabetology & metabolic syndrome, 17(1), 231. https://pubmed.ncbi.nlm.nih.gov/40533827/   Look, M., et al. (2025). Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, obesity & metabolism, 27(5), 2720–2729. https://pubmed.ncbi.nlm.nih.gov/39996356/   Wilding, J., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://pubmed.ncbi.nlm.nih.gov/33567185/   Tinsley, G. M., & Heymsfield, S. B. (2024). Fundamental Body Composition Principles Provide Context for Fat-Free and Skeletal Muscle Loss With GLP-1 RA Treatments. Journal of the Endocrine Society, 8(11),https://pubmed.ncbi.nlm.nih.gov/39372917/    Neeland, I. J., et al. (2024). Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, obesity & metabolism, 26 Suppl 4, 16–27. https://pubmed.ncbi.nlm.nih.gov/38937282/   Sato, M., et al. (2023). Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study. Journal of clinical medicine, 12(9), 3104. https://pubmed.ncbi.nlm.nih.gov/37176545/   Monami, M., et al. (2017). Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials. Diabetes, obesity & metabolism, 19(9), 1233–1241. https://pubmed.ncbi.nlm.nih.gov/28244632/   Anderson, S. L., & Trujillo, J. M. (2010). Association of pancreatitis with glucagon-like peptide-1 agonist use. The Annals of pharmacotherapy, 44(5), 904–909. https://pubmed.ncbi.nlm.nih.gov/20371755/   Kapoor, I., Sarvepalli, S. M., D'Alessio, D., Grewal, D. S., & Hadziahmetovic, M. (2023). GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials. Survey of ophthalmology, 68(6), 1071–1083. https://pubmed.ncbi.nlm.nih.gov/37454782/   Bikou, A., et al. (2024). A systematic review of the effect of semaglutide on lean mass: insights from clinical trials. Expert opinion on pharmacotherapy, 25(5), 611–619. https://pubmed.ncbi.nlm.nih.gov/38629387/   Jalleh, R. J., et al. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. The Journal of clinical endocrinology and metabolism, 110(1), 1–15. https://pubmed.ncbi.nlm.nih.gov/39418085/   Berg, S. AMA. (2023). Questions patients may have about weight-loss drugs. https://www.ama-assn.org/delivering-care/public-health/questions-patients-may-have-about-weight-loss-drugs   Friedman, J. (2025). America's up-and-down history with weight-loss drugs. https://www.history.com/articles/weight-loss-drugs-america    

Let's be honest, everyone's talking about GLP-1s (Ozempic, Wegovy, Zepbound), but no one's telling the whole story. Until now.This week, we're joined by the brilliant Dr. Alexandra Sowa—board-certified physician, NYU clinical instructor, founder of SoWell, and author of The Ozempic Revolution—for the ultimate deep dive into everything you actually need to know about navigating life on (and off) GLP-1s. From weight loss plateaus and blood sugar crashes to the infamous “Ozempic face,” nothing is off-limits. We break down the stigma, the science, and why it's not about getting thin—it's about getting healthy. We also unpack the tests your doctor probably isn't running (but should), the supplements that can make or break your progress, and why most people are doing GLP-1s totally wrong. Whether you're curious, committed, or just confused, this episode is your go-to guide to understanding your metabolism, hormones, and long-term health—without shame and without shortcuts. Mentioned in the Episode: SoWell GLP-1 Support System  The Ozempic Revolution by Dr. Alexandra Sowa HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) Calculator GLP-1 Medication Insurance Toolkit Your Friends & Neighbors (Apple TV) SoWell Electrolytes A Sony Music Entertainment production.  Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts and follow us at @sonypodcasts  To bring your brand to life in this podcast, email podcastadsales@sonymusic.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55______________________________________________________________________Dr. David Kessler, former FDA Commissioner and author of Diet, Drugs, and Dopamine, joins us to break down the science behind food addiction, obesity, and GLP-1 medications like Ozempic and Zepbound.He doesn't just study this—he lives it. Dr. Kessler has obesity, takes GLP-1s, and knows firsthand what it's like to battle food noise and weight stigma.In this episode, we discuss:What makes ultra-processed food addictiveHow GLP-1s affect the brain and reduce cravingsWhether some people can stop taking GLP-1sHis personal experience starting, stopping, and restartingWhy weight regain happens and what the body is really fightingHis bold policy ideas to regulate Big Food like Big TobaccoDr. Kessler helped bring HIV drugs to market faster, led Operation Warp Speed, and took on the tobacco industry. Now, he's focused on the next public health crisis: food addiction and obesity.Subscribe to The Plus SideZ Podcast for more expert conversations on GLP-1s, weight, and wellness.Specialist and Community Guest Dr. David KesslerBIO: David. A. Kessler, MD, served as chief science officer of the WhiteHouse COVID-19 Response Team under President Joe Biden and previouslyserved as commissioner of the US Food and Drug Administration underPresidents George H.W. Bush and Bill Clinton. He is the author of the_New York Times_ bestsellers _The End of Overeating_ and_ Capture_ andtwo other books:_ Fast Carbs, Slow Carbs_ and _A Question of Intent_.Dr. Kessler is a pediatrician and has been the dean of the medicalschools at Yale and the University of California, San Francisco. He is agraduate of Amherst College, the University of Chicago Law School, andHarvard Medical School.Social Media:https://x.com/DavidAKesslerMDLink to Book:https://www.audible.com/pd/B0D5KS9P4D?source_code=ASSORAP0511160006&share_location=pdpSpecial community guest Mike on a Health Mission Social MedSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro #zepbound #insurance #cvscaremark

Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. Today we're diving into a topic that's been everywhere lately: GLP-1 medications like semaglutide and tirzepatide for weight loss. You may know them by names like Wegovy, Ozempic, Mounjaro, or Zepbound. I want to give you a clear, realistic picture of what to expect—because while the media loves to highlight the dramatic before-and-after photos, the real journey can be slower and more nuanced for some. So in this episode, we're going to talk about the truth—what these medications can do, what they can't, how long things really take, and what you need to know to set yourself up for success. Not hype, not magic promises—just real, honest insight to help you understand the process. Let's get into it. How GLP-1 & GIP/GLP-1 Agonists Work So first things first—how do these meds work? Semaglutide is a GLP-1 receptor agonist, and tirzepatide is a dual GIP and GLP-1 receptor agonist. Basically, they mimic natural hormones in your body that help regulate blood sugar, slow digestion, and—most importantly for weight loss—reduce appetite and improve satiety. That means you feel fuller faster and stay full longer. You're not obsessing over food like before. And that's powerful. But—and this is a big one— these peptides don't magically erase years of weight gain overnight. What they do is help make weight loss easier by reducing hunger and supporting your metabolism—but they don't do all the work for you. It's important to remember they're a powerful tool, not a replacement for your efforts. You're still in control of your choices, habits, and long-term success. Why We Titrate the Dose—and What "Therapeutic Dose" Means Now, let's talk about dosing. When you start Wegovy, you don't start at the highest dose. It's gradually increased over several weeks to give your body time to adjust and to help reduce side effects like nausea or stomach upset. The usual schedule looks like this: You'll start with 0.25 mg once a week for the first month. Then it increases every four weeks—0.5 mg, then 1 mg, then 1.7 mg. By week 17, most people reach the full dose of 2.4 mg once a week—that's the dose shown in studies to lead to the most consistent weight loss, with many people losing around 15% of their total body weight over about a year. But here's the thing—not everyone follows this path exactly, and that's okay. Some people need to slow down or stay longer at a lower dose if they're having side effects. Others may need to increase sooner if they're not seeing appetite changes and are tolerating the medication well. And even though 2.4 mg is considered the “therapeutic dose,” not everyone needs to reach it. Some people feel great and lose weight at a lower dose—and if that's you, that's your sweet spot. The real goal is to find the lowest effective dose that controls your hunger, helps you lose weight at a steady pace, and keeps side effects to a minimum. This isn't a one-size-fits-all journey, and pushing through side effects just to hit the max dose isn't necessary—or safe. Your best dose is the one your body handles well and helps you make progress. *How Much Weight Can You Expect to Lose—and How Fast? Let's take a look at the clinical studies. In large trials, people on semaglutide lost about 15% of their total body weight over 68 weeks. For tirzepatide, it was even higher—20% or more in some cases. But here's the thing—those results happened over a year to a year and a half. Not 6 weeks. Not 3 months. It's a marathon, not a sprint. Also, most of the weight loss doesn't happen during the titration phase. You may see some weight loss early on, especially if your appetite plummets. But the bulk of the weight loss happens once you reach and maintain your therapeutic dose. Why Everyone's Journey Looks Different I can't stress this enough—everybody's journey is different. Some people feel zero hunger from their very first injection. Others don't notice a big change until week 10 or 12. Some drop 10 pounds in the first month. Others lose two pounds and feel discouraged. All of those experiences are normal. Your age, hormones, medications, stress levels, sleep, and past diet history? They all play a role. And let's be real—gaining 20, 50, or 100 pounds didn't happen in a few weeks, right? It likely took months or even years of lifestyle habits, hormonal shifts, emotional eating, or underlying conditions. So we have to give ourselves that same grace and patience when we're trying to take the weight off—even with medical support. Navigating Side Effects and Setbacks Let's talk about the side effects. Nausea, constipation, acid reflux, bloating—yeah, these are pretty common as your body adjusts. And sometimes, those symptoms are your body's way of saying: Hey, slow down. Pushing through intense side effects just to hit a higher dose isn't the goal. In fact, it's not safe. You want the lowest effective dose that keeps your appetite under control, the weight coming off gradually, and your side effects minimal or nonexistent. If you need to pause treatment to let your gut settle or even go back down a dose, that's not failure. That's smart, safe self-care. We're in this for the long haul. Trial and Error with Food—and That's OK One part of this journey that catches people off guard is how sensitive your stomach becomes—especially to certain foods or drinks. Greasy or fried foods, spicy meals, carbonated drinks, alcohol—these can all be triggers for nausea or even vomiting while you're on this medication.  And it makes sense when you think about it: the medication slows down how quickly food and drink leave your stomach. So if you're eating or drinking things that already tend to irritate the stomach lining, the effects can hit harder and last longer. Even if those foods didn't bother you before starting treatment, they might now. It's just one of those things your body has to adjust to, and it may take some trial and error to figure out what still works for you. What is Healthy, Sustainable Weight Loss? So what's a healthy pace of weight loss? In general, 1 to 2 pounds per week is considered safe and sustainable. But on GLP-1s, that might vary. Some weeks you may lose 3 pounds. Some weeks, nothing. And guess what? That's normal. You're looking for overall downward trends, not perfection. The goal here is steady, sustainable fat loss—not dropping weight so quickly that you feel miserable, drained, or start losing muscle. Remember, we're not chasing “skinny”—we're aiming for strong, lean, energized, and healthy. And I know we've talked about this before, but it's worth repeating: exercise is not optional when you're on a GLP-1. It's a must. When you lose weight, you lose both fat and muscle. If you're not actively working to maintain or build muscle, you risk becoming weaker and slowing down your metabolism in the process. We want to keep the muscle you have—and ideally, build more—so your body stays strong and your results last. What Is a “Non-Responder”? Now let's touch on something important: what if the medication doesn't seem to work? Let's talk about what it means to be a “non-responder” on a GLP-1 medication like Wegovy or Zepbound. In clinical terms, a non-responder is someone who has been on their therapeutic dose for at least 3 months and has lost less than 5% of their total body weight—even though they're taking the medication correctly and making lifestyle changes like adjusting their diet, increasing physical activity, and managing stress or sleep. Let's break that down with an example: If someone weighs 200 pounds, 5% of their total body weight would be 10 pounds. So if they've been on their therapeutic dose for 12 weeks and have only lost, say, 4 or 5 pounds—despite doing everything right—they may be considered a non-responder. But as we mentioned before, everyone's therapeutic dose may be different. The therapeutic dose isn't just the maximum dose like 2.4 mg of semaglutide or 15 mg of tirzepatide. It's the dose at which you personally begin to experience consistent appetite suppression, weight loss, and minimal side effects. For some people, that may happen at 1 mg of semaglutide. Others may not feel much of a difference until they reach the full 2.4 mg. Some may even respond better at 1.7 mg and not tolerate the higher dose at all. That's why we titrate slowly, monitor your symptoms, and assess both how you feel and how your body is responding. So how do we know if you've reached your therapeutic dose? We look at things like: Has your appetite significantly decreased? Are you noticing earlier fullness or fewer cravings? Are you losing weight consistently over time Are side effects tolerable or nonexistent? If the answer is yes, you're probably at your therapeutic dose. But if the answer is no—if your hunger hasn't changed much, the scale hasn't moved, and you're not noticing any shift in your eating patterns after 3 months on a stable, higher dose—it might be time to re-evaluate. That could mean adjusting the dose, checking for other health issues that might be interfering (like thyroid problems or certain medications), or even considering a different treatment approach. *So what are my final thoughts?  Your journey is unique. Not everyone responds the same way, and that's okay. The key is finding what works for your body, not just what the label says. These medications can absolutely change lives. But they're not magic. They work with your efforts—not instead of them. You'll need to be patient, flexible, and kind to yourself along the way. You may need to tweak your dose, change your food choices, or give your body time to adjust. That's part of the process. And remember—this isn't just about weight loss. It's about reclaiming your health, confidence, and energy. So take it one step at a time. Celebrate every win. And know that slow progress is still progress. Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Until next time, be well, be patient, and keep showing up for yourself. And as always, have a happy, healthy week.

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:The information to collect during patient visitsThe available resources to help you submit prior authorizationsThe supporting documents that are often necessary to accompany prior authorizationsHow to address denials and appealsWhen to access manufacturer-based or foundation-based financial assistancePresentersJoseph Kim, MD, MPH, MBAPresidentQ Synthesis, LLCNewtown, PennsylvaniaManish Shah, MDClinical Associate Faculty MS1 PreceptorUniversity of Florida College of MedicineGainesville, FloridaMartha Grugel, MAMedical AssistantWesley Chapel, FloridaLink to full program: https://bit.ly/45P0v8z

Weight loss drugs are everywhere and recently Zepbound (tirzepitide) made big news when it became the first FDA-approved sleep apnea therapy for mild to moderate sleep apnea. In this episode, we will:Introduce and explain weight loss medicationsReview the studies that convinced the FDA to approve Zepbound for sleep apneaProvide an overview on this class of weight loss medicationsEvaluate the risks and determine who is a best match for this therapyTouch on the cost and difficulty in getting these drugs approvedRevisit Apnimed's SynAIRgy press release and how it relates to our discussion in episode 110 of the podcastProduced by: Maeve WinterMore Twitter: @drchriswinter IG: @drchriwinter Threads: @drchriswinter Bluesky: @drchriswinter The Sleep Solution and The Rested Child Thanks for listening and sleep well!

What if your best body, clearest mind, and strongest sense of purpose were still ahead of you? That's the question I explore in this episode with Richard Rosenfeld, MD, MPH, MBA. He's a board-certified ENT, Director of Guidelines and Quality at the American College of Lifestyle Medicine, and one of the most published ENT researchers in the world—with nearly 400 peer-reviewed articles to his name. But what really sets Rich apart is his personal story. In his mid-50s, he hit a turning point—and decided to change course. He adopted a whole food, plant-based lifestyle. Picked up strength training again after decades off. Started running. Now, in his 60s, he's finished 10 marathons, lifts consistently, and says he feels sharper and more alive than ever. In This Episode, We Dive Into: What sparked Rich's midlife transformation How he fuels, trains, and recovers today Strength training after 50 and the role of protein and creatine His honest take on GLP-1 meds (like Wegovy and Zepbound) for weight loss And how mindset, curiosity, and purpose fuel long-term change We also talk about the culture of medicine—and what it'll take to build a system that actually supports health, not just disease management. This conversation is full of science-backed insight and lived experience. And it's a story that reminds you what's possible—no matter your starting point. Live well and RAK ON, Dr. Rak

Welcome back to Diamond Paint and Podcast — where I ramble, reflect, and real-talk my way through a diamond painting session.In this episode, we're all over the place in the best way possible. I'm chatting about:The “Donut Mom” at cheerleading

In this Trending Health series, Vynamic team members will highlight how different sectors of the health industry are evolving to meet the demands of today's ever-changing healthcare landscape through value creation and strategic transformations.In this episode, Mindy McGrath, Saurabh Raman, and Ryan Hummel dive into how payers are shifting from short-term cost cutting to long-term strategic transformation as a result of rising costs, policy upheaval, and evolving consumer demands.To learn more about how we can help your team navigate these strategic decisions, reach out to Saurabh.Raman@vynamic.com and Ryan.Hummel@vynamic.com. Podcast Tags: healthcare, health plan, healthcare strategy, health innovation, strategic transformation Source Links:Medical cost trend: Behind the numbers 2025 UnitedHealth reports highest medical costs since COVID-19 pandemic's start New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200 Spending growth on GLP-1s outpaces specialty drugs: Evernorth study Elevance Health Reports First Quarter 2024 Results Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel Research & Production – Julia Morrison, Saurabh Raman, Ryan Hummel, Everly PetruzzelliRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com. 

Americans are unusually overweight and chronically ill compared to similarly rich countries. This episode presents a grand, unified theory for why that's the case. Our food environment has become significantly more calorie-rich and industrialized in the past few decades, sending our obesity rates soaring, our visceral fat levels rising, and our chronic inflammation surging. The result is an astonishing rise in chronic illness in America. That's the bad news. The good news is that GLP-1 drugs, like Ozempic and Zepbound, seem to be astonishingly successful at reversing many of these trends. This episode blends two interviews with Dr. David Kessler and Dr. Eric Topol. Kessler was the commissioner of the Food and Drug Administration under the Bush and Clinton administrations, from 1990 to 1997. He helped lead Operation Warp Speed in its final months. He is the author of the book 'Diet, Drugs, and Dopamine.' Topol is a cardiologist and the founder and director of the Scripps Research Translational Institute. He is the author of the book 'Super Agers.' If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Dr. David Kessler and Dr. Eric Topol Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

It's only June. That means you still have six full months to change your life. Seriously. Who do you want to be when the ball drops on December 31st?Are you going to be crying in the bathroom again because nothing fits? Googling “how to lose weight fast” for the hundredth time? Or are you going to feel proud as hell that you didn't give up on yourself this time?In this episode, I'm talking about what's actually possible in six months and how showing up with consistency (not perfection!) can transform how you feel, how you live, and how you see yourself.If you're tired of starting over every Monday, hating your life, emotionally eating your days away, and waiting for “the right time,” this is your wake-up call.Let's talk about who you could be by the end of the year and how to start becoming her now.

SUPPORT OUR WORK AND GET MORE NEWS! https://linktr.ee/manonthemounjaro

 We know GLP-1 meds are still a hot topic, so wanted to share our journey with you all. We both came to the decision to start taking Zepbound after coming off Mounjaro in 2023. Tune in and listen to why we chose to start Zepbound, what method we are using and what we hope to achieve. In this episode, we also discuss what we learned from Mounjaro just a few years ago to help us prepare for part 2 of this journey. We both spoke to our doctors and explained what we were hoping to achieve and they were both on board. We are THRILLED that medical professionals are willing to help fight this disease of obesity, no matter what it takes! And we are both fortunate enough to have those caring and invested doctors to aid us in this journey. Both doctors covered with us how to properly pull the injection and how to administer it. Explained possible side effects, talked about diet and exercise in a caring and helpful manner. All the things that we deserve as humans in this battle for health! Our advice? If your doctor isn't willing to walk the path with you... FIND A NEW DOCTOR! Like now! The only missing puzzle piece here is to get the insurance companies up to speed. Neither of our insurance companies will cover the drug. So, we had to seek alternate routes to make it affordable. Tune in if you're curious to hear more about that, as we explain it in detail in this episode. We are excited to kick off this new journey and we're looking forward to taking you along for the ride! Follow Justy & Steph on Instagram, where they share their weight loss journey and road to living a happy & healthy lifestyle.@we.are.losing.it If you prefer video to see us talk through our topics, you can watch us on YouTube. https://youtube.com/@wearelosingitShow your support by hitting download, like & subscribe! We truly appreciate each and every one of you!!

Je leest het goed. De rijkste man van de wereld heeft miljarden nodig. Geld dat 'ie gebruikt om zijn AI-imperium uit te bouwen. Het moet dé concurrent worden van OpenAI. Een bedrijf dat dan weer écht in oorlog ligt met Microsoft.We hebben het er deze aflevering over. Dan hebben we het ook over die echte oorlog. Die tussen Israël en Iran. In Iran smeken ze president Trump om een wapenstilstand in te lassen, maar daar heeft hij geen trek in. Waardoor de onzekerheid op de beurs (voor jou) nog langer aanhoudt.We ontdekten trouwens dat het ondanks die oorlog prima beleggen is in Tel Aviv. Nou ja prima. Fantastisch. Waarom dat is, je raadt het al: daarvoor moet je toch echt luisteren.Hoor je ook meer over een miljardenovername van Eli Lilly en de handelsdeal die Trump heeft gesloten met de EU. Of was het nu met het Verenigd Koninkrijk? See omnystudio.com/listener for privacy information.

Ian Bremmer, president of the Eurasia Group, joins "CBS Mornings" to break down a weekend of deep division in the U.S., as millions protested President Trump and his military parade, and deadly new strikes between Iran and Israel raised fears of a wider regional war in the Middle East. The jury in Karen Read's retrial began deliberations Friday afternoon and will continue Monday. Read is facing three charges in the 2022 death of her police officer boyfriend, John O'Keefe, including second-degree murder. Her first trial ended with a hung jury. Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' Nancy Chen reports on the qualifications for the discount and what the cost reduction will be. Artificial intelligence is being used to create realistic video and audio to impersonate people, in some cases looking for love or deceiving companies looking to hire. In a 2024 study, half of the businesses surveyed said they'd experienced AI deepfake fraud. CBS News MoneyWatch correspondent Kelly O'Grady reports. In this week's "Beg-Knows America," CBS News contributor David Begnaud revisits the life-changing world of high school speech and debate, an activity that shaped his own path. He meets the inspiring young voices featured in the new documentary "SPEAK," tackling grief, identity, and advocacy with extraordinary courage. Consumer Reports' deputy editor Brian Vines joins "CBS Mornings" to share the latest sunscreen testing results, including top-rated picks and expert tips to keep you and your family safe in the sun this summer. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Welcome to the first episode of Diamond Paint and Podcast — a cozy space where I decompress, diamond paint, and talk through the emotional weight of everyday life.This series is for those of us who are just trying to feel like ourselves again one tiny sparkle at a time. No filters, no scripts, no pressure. Just real talk while I work on something that feeds my soul.In this first episode, I'm catching you up on life lately, how I've been feeling, and where my head's been. It's not polished. It's not planned. It's just me decompressing, rambling, and trying to process the chaos with a side of bling!

Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, includingDiscussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can helpMeeting patients where they are at and offering slow, incremental changes that support long-term outcomesReferring patients to community resources and other professionals as needSharing lessons learned for those interested in implementing similar strategies in their practice PresenterJoseph Kim, MD, MPH, MBAPresidentQ Synthesis, LLCNewtown, PennsylvaniaNatalie Orbach, PA-CPhysician AssistantFeirtag & Ramos, PALutherville, Maryland Link to full program: https://bit.ly/45P0v8z

More and more people with type 1 are using GLP-1 receptor agonists. You know these medications, with brand names like Ozempic, Mounjaro, Wegovy and Zepbound, but none of them are specifically approved to treat T1D. Some of the first studies are underway to study the safety and effectiveness of GLP-1s, but that hasn't stopped thousands of using them off-label or to treat obesity. We're talking to an endocrinologist and a clinical pharmacist about why they prescribe these meds to some of their type 1 patients, who they won't prescribe them for, and – I know you're already asking – how they get insurance coverage.   My guests are endocrinologist Dr. Adam Spitz and Clinical Pharmacist Georgina Farrow GLP news story Stacey references here Dr Spitz's medical thriller here This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

You ever lie in bed at night, thinking about all the things you're going to do tomorrow, like wake up early, eat better, clean the house, work out, be more present, but then tomorrow comes… and you're right back in survival mode? Girl, I get it! Please hear this: you're not lazy - you're at maximum capacity. In this episode, I'm getting real about the exhaustion of good intentions that never get met, the emotional weight of feeling stuck, and the shame that sneaks in when you know you're capable of more but can't seem to show up. If you're just getting by and tired of feeling like you're failing… this one's for you.

Did you know a daily weight loss pill might soon replace weekly injections for managing obesity? In this episode, I explore the exciting new development of a once-daily oral weight loss medication, oral semaglutide 50mg highlighting results from the OASIS 1 trial. With this, I explain how this pill could be a game-changer for people who are hesitant about injections like Wegovy or Zepbound. I break down how semaglutide works as a GLP-1 receptor agonist, the phases of drug development, and the impressive trial results showing an average 15% body weight loss in participants without diabetes. I also talk about common side effects, the FDA approval timeline, and what this could mean for patients looking for more accessible, convenient weight loss options. Curious about the future of weight loss treatments? Tune in to learn about a groundbreaking pill that could change everything.   Episode Highlight: Introduction of oral semaglutide 50mg as a potential weight loss pill  Explanation of how semaglutide works as a GLP-1 receptor agonist. Overview of the OASIS 1 phase 3 trial Breakdown of clinical trial phases and FDA approval process. Discussion of side effects Adherence rates and significant weight loss among participants. Insight into future FDA approval timelines and potential market release Importance of combining medication with lifestyle changes Considerations about insurance coverage and patient access   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

In this solo episode, Dr. Marianne explores how the growing popularity of GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro is reshaping the body diversity movement. As weight loss drugs become more widely used and celebrated, messages of fat liberation and weight-inclusive care are being challenged in new and complex ways. Dr. Marianne discusses the cultural effects of GLP-1s, the pressure many people feel to conform to changing body ideals, and what this means for fat humans, eating disorder recovery, and those committed to body autonomy. This episode offers a compassionate and honest look at the grief, confusion, and questions arising in this new era. If you're navigating the intersection of weight stigma, eating disorders, and the rise of GLP-1 medications, this conversation will help you feel grounded, supported, and less alone.

In a groundbreaking development for the digital health world, Eli Lilly, one of the world's largest pharmaceutical companies, has filed lawsuits against a growing number of telehealth companies over the sale of compounded drugs Mounjaro and Zepbound, two popular GLP-1 medications. Nawa Lodin, Associate, Wilson Sonsini Goodrich & Rosati, and Lauren Petrin, Associate, Wiley Rein, discuss the background of compounding and when it is allowed under FDA regulations; the legal and regulatory issues at play in Eli Lilly's lawsuits, including issues related to the corporate practice of medicine and FDA regulations; and key compliance considerations. Watch this episode: https://www.youtube.com/watch?v=XstaVQGtY24AHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

In this powerful and unapologetic episode, I sit down with Dr. Tyna Moore — physician, author, and outspoken advocate for evidence-based metabolic health — for a deeply candid conversation about peptides, GLP-1s (like Ozempic, Mounjaro, Wegovy, and Zepbound), and why the current medical system is failing women. We dive into:

Dr. Fiona Lovely is a longevity, health and wellness expert with specialties in menopause medicine, functional neurology, and functional medicine. She is speaking to the topics of women's health around perimenopause and menopause. In this week's episode, Dr. Fiona Lovely sits down with Angelo Keely, nutrition and protein optimization enthusiast.  Together, they dive into the powerful, science-backed role of protein and amino acids in supporting women's health—especially in midlife and beyond. Angelo unpacks why protein needs actually increase with age, particularly for women going through menopause. From fighting muscle loss (sarcopenia) to supporting bone health, metabolism, and mood, getting enough high-quality protein is essential—but often overlooked. You'll learn smart strategies to meet your protein goals without overeating, the key differences between protein powders and essential amino acids (EAAs), and how targeted supplements like creatine and EAAs can dramatically boost muscle and cognitive health—even without intense workouts. They also address the risks of rapid weight loss with GLP-1 medications (like Ozempic or Zepbound), and how pairing these with resistance training and amino acid support can help preserve lean mass and vitality. Topics We Cover in This Episode: Why women over 40 need more protein, not less How sarcopenia sneaks in—and how to stop it High-protein food tips: egg whites, Greek yogurt, lean meats & more EAAs vs. protein powder: what your body really absorbs NASA studies, amino acids & maintaining muscle without exercise Creatine for women: not just for gym bros GLP-1s & supporting strong muscles when taking it Simple, sustainable tips for strong, energized aging You can find more about Angelo and KION and about the Aminos product we speak about in this epsiode by visiting getkion.com/lovely (and there is a 20% off code - LOVELY) “Breathe. Be patient. Trust the process.” – Angelo Keely

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Ever lost a lot of weight like 40, 50 pounds or more and noticed some unexpected changes in your body?In today's episode, we're talking about the surprising (and sometimes downright weird) side effects that don't get mentioned much when it comes to major weight loss—whether it's from lifestyle changes or medications like Zepbound or Wegovy.For example, some people develop Eustachian tube dysfunction, which can make your ears feel blocked or pop unexpectedly. Sitting might even feel uncomfortable now that the fat cushioning your tailbone is gone.Then there's “slimmer's paralysis”—a temporary nerve irritation that can pop up when the fat around certain nerves disappears. You might also spot new lumps or bumps, or find yourself feeling colder than usual since fat helps keep you warm.Other changes can include lower blood pressure and shifts in your menstrual cycle as your body adjusts.Want to hear more about these lesser-known effects and how to deal with them? Tune in to the full episode!Connect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

✨ My GLP-1 Girlie group program is opening again at the end of February for enrollment for a 3/2/25 start date.

Episode 2647: Vinnie Tortorich and Chris Shaffer discuss traveling, going down a bad road with GLP-1s and muscle loss, and more. https:vinnietortorich.com/2025/05/going-down-a-bad-road-episode-2647 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE -  Going Down A Bad Road Vinnie is traveling soon and is looking forward to going back home for crawfish season. (2:30) A good road trip is a nice “mental massage.” (5:15) He shares what he packs for the road trip. All of Vinnie's businesses will be consolidated into one website soon. (16:00) Pure Vitamin Club, Pure Coffee Club, and NSNG Foods will be available on one website. Chris brings up Good Morning America and GLP-1s. (18:00) Zepbound is being touted as the most effective, but, of course, it will come at a cost. The drastic loss of muscle is a concern; after all, your heart is a muscle! Ten percent (the low-end percentage) of muscle loss in the 60 to 72 week time span is the same as 20 yearsof sarcopenia. (25:00) They give an example of a VIP member who has been slow to lose weight; however, they have figured out this person is undereating! Your metabolism can slow down if you aren't getting enough calories. It can be as simple as adding another egg or two to make sure you are getting enough. This is the challenge with intermittent fasting and OMAD (one meal a day) approaches to eating. If you allow yourself to eat a treat, just get right back on the NSNG® plan. If you aren't sure how to get started with NSNG®, get Vinnie's e-book.  Chris shares some of his weight loss journey.  (42:00) He discovered his wheat and gluten sensitivity after stopping eating certain foods like pizza and pasta. Now he is so well-tuned with his health, he can tell if even a small amount of wheat is in his food. Avoid processed foods; they are addictive and damaging to your health. More News If you are interested in the NSNG® VIP group is currently closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook, is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.  There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/   PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

In this episode of the Irresistible You podcast, we're talking about the importance of finding your soul snack—something that feeds your soul so you're not constantly turning to food for comfort. Since Chuy passed away, my nights have felt painfully quiet. He was my constant companion during the late-night hours when the house finally settled. That kind of loss leaves a void, but here's the thing… I didn't slip back into emotional eating, and that's because I already had the Irresistible You framework to guide me.One of the most powerful tools in that framework? Feed Your Soul.Lately, diamond painting has been helping me fill that space with peace instead of food. Let's talk about why you need a soul snack and how to find one that works for you.If you've ever reached for food when what you really needed was something deeper, this episode is for you.

Listen as Gaining Health host, Karli Burridge, reflects on the OMA Annual Conference with Sam and Joe!Petition to keep Zepbound on formulary:  https://www.change.org/p/stop-cvs-caremark-s-zepbound-ban-restore-coverage-of-the-superior-obesity-medicationSandra Christensen is board-certified as a family nurse practitioner and holds the Certificate of Advanced Education in Obesity Medicine from the Obesity Medicine Association. She is the founder and Chief Clinical Officer of Integrative Medical Weight Management in Seattle, Washington, and has specialized in obesity management since 2005. She is a Master Fellow of the Obesity Medicine Association and a Fellow of the American Association of Nurse Practitioners. She serves on the Board of Trustees for the Obesity Medicine Association and is the President of the Washington Obesity Society.  She authored the book, “A Clinician's Guide to Discussing Obesity with Patients” published by Springer, and was named the 2022 Obesity Medicine Association Clinician of the Year.The Washington Obesity SocietyIntegrative Medical Weight Managementhttps://www.linkedin.com/in/sandra-christensen/Joseph Zucchi (pronounced Zoo-key) is a board-certified Physician Assistant and Personal Trainer who serves as the Clinical Supervisor of Transition Medical Weight Loss in Salem, New Hampshire. With over a decade of experience in obesity medicine, Joe leads a multidisciplinary team dedicated to helping patients achieve sustainable weight loss and improved health. He has worked with over 2,000 patients to collectively lose more than 40,000 pounds. Joe integrates fitness, nutrition, and medical interventions to provide comprehensive, patient-centered care.  His work has been recognized through multiple accolades, including leading Transition Medical Weight Loss to win awards for best weight loss center in NH. He has written articles and has shared his expertise on obesity care and weight-loss treatments in outlets like the Wall Street Journal, MedPage Today, Healthline, and Doximity. Joe also is a speaker for Eli Lilly and educates other providers about Zepbound and obesity medicine. https://www.linkedin.com/in/josephzucchi/https://x.com/JPZfitnesshttps://transitionsalem.com/Support the showThe Gaining Health Podcast will release a new episode monthly, every second or third Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer a Roadmap to starting an obesity program or practice, pre-recorded Master Classes, digital resources including patient education materials and office forms, and much more! Check out our resources on our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro

✨ My GLP-1 Girlie group program is opening again at the end of February for enrollment for a 3/2/25 start date.

Did you know that some weight loss medications can help people lose up to 20% of their body weight, comparable to bariatric surgery outcomes? In this episode, I dive into the latest research comparing two major weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide), based on findings from the 72-week SURMOUNT-5 trial. I explain how Zepbound led to greater weight loss (about 20.2% vs. 13.7% with Wegovy), possibly due to its dual action on GIP and GLP-1 receptors. Both drugs were generally well tolerated, with similar side effects like nausea and constipation, though Wegovy had slightly more people stop due to GI issues. I also emphasize that while Zepbound may appear more effective, individual needs, such as cardiovascular health or sleep apnea, should guide treatment decisions. Lastly, I remind you that sustainable weight loss requires patience, realistic expectations, and a holistic approach that includes lifestyle changes, not just medication. Tune in to this episode to learn which weight loss medication might be right for you and why your journey to health is more than just the number on the scale.   Episode Highlights: Comparison of Wegovy (semaglutide) and Zepbound (tirzepatide) Average weight loss outcomes and waist circumference changes between both medications Mechanism of action: GLP-1 vs. dual GIP/GLP-1 receptor targeting Side effect profiles and tolerability of both medications FDA approval differences, including cardiovascular risk reduction and sleep apnea treatment Importance of personalized treatment plans and setting realistic weight loss expectations Ongoing research into oral formulations and long-term safety studies Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

There is an abundance of data on the impact of coffee drinking on health. Dr. Lisa shares the data on the way coffee impacts our risk for premature death, diabetes, depression, heart disease, stroke, Parkinson's disease, dementia, and other health conditions. She also dives in to the impact of coffee on weight loss, of course. And for those taking GLP1 agonists like Wegovy or Ozempic (or GLP/GIP meds like Zepbound or Mounjaro), she reviews the data on coffee and sarcopenia, which is muscle loss.This episode is filled with myth busting surprises about coffee and health. Of course there are downsides to coffee, so if you're pregnant, or you find that coffee causes palpitations, worsening anxiety, or insomnia for you, then it's probably time to rethink your drink or cut down on your coffee. Thanks for listening! If you'd like more support during your SMART weight loss & health focused journey, sign up for our FREE newsletter, or check out our program at: www.SmartWeightLossCoaching.com. We would love to help you reach your happy weight, and transform the way you talk to yourself about your body and the number on the scale. Negative thoughts about yourself don't have to take up so much brain space, and we'd be honored to help you reframe those thoughts. Also…We'd be grateful if you'd follow us and share our podcast with your friends & family. We're here to help you (and those you love) improve your health, live longer, healthier, and lose weight the SMART way! This episode was produced by The Podcast Teacher: www.ThePodcastTeacher.com.

Tirzepatide is more effective for weight loss than semaglutide.Cost-effectiveness is crucial in prescribing weight loss medications.Patients with severe obesity should receive more expensive medications for better outcomes.Both medications show significant benefits for obesity-related conditions.Long-term studies indicate sustained weight loss with both drugs.Gender differences affect weight loss outcomes with these medications.Safety profiles show tirzepatide may be better tolerated than semaglutide.The need for affordable drug pricing is emphasized.Clinical benefits extend beyond weight loss to include metabolic health.Future studies are needed to confirm cardiovascular benefits of tirzepatide.Click here to see the studyClick here to join Dr. Spencer's new online clinic